Report Detail

Pharma & Healthcare Global Paclitaxel Injection Market Growth 2019-2024

  • RnM2925336
  • |
  • 11 February, 2019
  • |
  • Global
  • |
  • 166 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Global Paclitaxel Injection Market Growth 2019-2024

Table of Contents

    2019-2024 Global Paclitaxel Injection Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Paclitaxel Injection Consumption 2014-2024
        • 2.1.2 Paclitaxel Injection Consumption CAGR by Region
      • 2.2 Paclitaxel Injection Segment by Type
        • 2.2.1 Drug Strength
        • 2.2.2 Raw meterial Paclitaxel API source
      • 2.3 Paclitaxel Injection Consumption by Type
        • 2.3.1 Global Paclitaxel Injection Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Paclitaxel Injection Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Paclitaxel Injection Sale Price by Type (2014-2019)
      • 2.4 Paclitaxel Injection Segment by Application
        • 2.4.1 Ovarian cancer
        • 2.4.2 Breast cancer
        • 2.4.3 Cervical cancer
        • 2.4.4 Pancreatic cancer
        • 2.4.5 Other
      • 2.5 Paclitaxel Injection Consumption by Application
        • 2.5.1 Global Paclitaxel Injection Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Paclitaxel Injection Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Paclitaxel Injection Sale Price by Application (2014-2019)

      3 Global Paclitaxel Injection by Players

      • 3.1 Global Paclitaxel Injection Sales Market Share by Players
        • 3.1.1 Global Paclitaxel Injection Sales by Players (2017-2019)
        • 3.1.2 Global Paclitaxel Injection Sales Market Share by Players (2017-2019)
      • 3.2 Global Paclitaxel Injection Revenue Market Share by Players
        • 3.2.1 Global Paclitaxel Injection Revenue by Players (2017-2019)
        • 3.2.2 Global Paclitaxel Injection Revenue Market Share by Players (2017-2019)
      • 3.3 Global Paclitaxel Injection Sale Price by Players
      • 3.4 Global Paclitaxel Injection Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Paclitaxel Injection Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Paclitaxel Injection Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Paclitaxel Injection by Regions

      • 4.1 Paclitaxel Injection by Regions
        • 4.1.1 Global Paclitaxel Injection Consumption by Regions
        • 4.1.2 Global Paclitaxel Injection Value by Regions
      • 4.2 Americas Paclitaxel Injection Consumption Growth
      • 4.3 APAC Paclitaxel Injection Consumption Growth
      • 4.4 Europe Paclitaxel Injection Consumption Growth
      • 4.5 Middle East & Africa Paclitaxel Injection Consumption Growth

      5 Americas

      • 5.1 Americas Paclitaxel Injection Consumption by Countries
        • 5.1.1 Americas Paclitaxel Injection Consumption by Countries (2014-2019)
        • 5.1.2 Americas Paclitaxel Injection Value by Countries (2014-2019)
      • 5.2 Americas Paclitaxel Injection Consumption by Type
      • 5.3 Americas Paclitaxel Injection Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Paclitaxel Injection Consumption by Countries
        • 6.1.1 APAC Paclitaxel Injection Consumption by Countries (2014-2019)
        • 6.1.2 APAC Paclitaxel Injection Value by Countries (2014-2019)
      • 6.2 APAC Paclitaxel Injection Consumption by Type
      • 6.3 APAC Paclitaxel Injection Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Paclitaxel Injection by Countries
        • 7.1.1 Europe Paclitaxel Injection Consumption by Countries (2014-2019)
        • 7.1.2 Europe Paclitaxel Injection Value by Countries (2014-2019)
      • 7.2 Europe Paclitaxel Injection Consumption by Type
      • 7.3 Europe Paclitaxel Injection Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Paclitaxel Injection by Countries
        • 8.1.1 Middle East & Africa Paclitaxel Injection Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Paclitaxel Injection Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Paclitaxel Injection Consumption by Type
      • 8.3 Middle East & Africa Paclitaxel Injection Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Paclitaxel Injection Distributors
      • 10.3 Paclitaxel Injection Customer

      11 Global Paclitaxel Injection Market Forecast

      • 11.1 Global Paclitaxel Injection Consumption Forecast (2019-2024)
      • 11.2 Global Paclitaxel Injection Forecast by Regions
        • 11.2.1 Global Paclitaxel Injection Forecast by Regions (2019-2024)
        • 11.2.2 Global Paclitaxel Injection Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Paclitaxel Injection Forecast by Type
      • 11.8 Global Paclitaxel Injection Forecast by Application

      12 Key Players Analysis

      • 12.1 Bristol-Myers Squibb
        • 12.1.1 Company Details
        • 12.1.2 Paclitaxel Injection Product Offered
        • 12.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Bristol-Myers Squibb News
      • 12.2 Celgene Corporation
        • 12.2.1 Company Details
        • 12.2.2 Paclitaxel Injection Product Offered
        • 12.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Celgene Corporation News
      • 12.3 Hospira
        • 12.3.1 Company Details
        • 12.3.2 Paclitaxel Injection Product Offered
        • 12.3.3 Hospira Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Hospira News
      • 12.4 Biological E.
        • 12.4.1 Company Details
        • 12.4.2 Paclitaxel Injection Product Offered
        • 12.4.3 Biological E. Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Biological E. News
      • 12.5 Taj Accura
        • 12.5.1 Company Details
        • 12.5.2 Paclitaxel Injection Product Offered
        • 12.5.3 Taj Accura Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Taj Accura News
      • 12.6 Khandelwal Laboratories
        • 12.6.1 Company Details
        • 12.6.2 Paclitaxel Injection Product Offered
        • 12.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Khandelwal Laboratories News
      • 12.7 Luye Pharma
        • 12.7.1 Company Details
        • 12.7.2 Paclitaxel Injection Product Offered
        • 12.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Luye Pharma News
      • 12.8 Beijing Youcare
        • 12.8.1 Company Details
        • 12.8.2 Paclitaxel Injection Product Offered
        • 12.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Beijing Youcare News
      • 12.9 Beijing Union
        • 12.9.1 Company Details
        • 12.9.2 Paclitaxel Injection Product Offered
        • 12.9.3 Beijing Union Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Beijing Union News
      • 12.10 Haiyao
        • 12.10.1 Company Details
        • 12.10.2 Paclitaxel Injection Product Offered
        • 12.10.3 Haiyao Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Haiyao News
      • 12.11 Chuntch

      13 Research Findings and Conclusion

      Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
      Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

      In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

      In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

      In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

      At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

      In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

      According to this study, over the next five years the Paclitaxel Injection market will register a 11.0% CAGR in terms of revenue, the global market size will reach US$ 3680 million by 2024, from US$ 2180 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Paclitaxel Injection business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Injection market by product type, application, key manufacturers and key regions and countries.

      This study considers the Paclitaxel Injection value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Drug Strength
      Raw meterial Paclitaxel API source
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Ovarian cancer
      Breast cancer
      Cervical cancer
      Pancreatic cancer
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Bristol-Myers Squibb
      Celgene Corporation
      Hospira
      Biological E.
      Taj Accura
      Khandelwal Laboratories
      Luye Pharma
      Beijing Youcare
      Beijing Union
      Haiyao
      Chuntch

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Paclitaxel Injection consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Paclitaxel Injection market by identifying its various subsegments.
      Focuses on the key global Paclitaxel Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Paclitaxel Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Paclitaxel Injection submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.


      Summary:
      Get latest Market Research Reports on Paclitaxel Injection . Industry analysis & Market Report on Paclitaxel Injection is a syndicated market report, published as Global Paclitaxel Injection Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Paclitaxel Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      3,015.36
      4,523.05
      6,030.73
      3,298.42
      4,947.63
      6,596.84
      389,621.64
      584,432.46
      779,243.28
      261,886.18
      392,829.26
      523,772.35
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report